Biotech

All Articles

BMS axes bispecific months after submitting to work phase 3 test

.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...

Charles Baum consumes Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squ...

Asarina to shut after efforts to companion Tourette's drug fall short

.After reaching out to greater than 200 companies to companion a Tourette disorder treatment that re...

Novartis pens $150M upfront bispecifics cope with Dren Bio

.Novartis has possessed some bad luck along with bispecific antibodies in the past, but evaluating d...

AstraZeneca plants an EGFR tree along with Pinetree bargain worth $45M

.Pinetree Rehabs are going to assist AstraZeneca plant some plants in its own pipeline along with a ...

GRO gathers $60M series B to take gout pain treatment in to clinic

.GRO Biosciences has ended the full week along with an added $60.3 million in the banking company, w...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses chief executive officer

.Welcome to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, firings ...